Sai Life Sciences
NSE: SAILIFE · ISIN INE570L01029 · Healthcare
₹1,824.80+80.80 (+4.63%)
Monday 9 November, 12:04 IST. Delayed. Source: Yahoo Finance.
Price chart
₹1,824.80 +80.80 (+4.63%) today
The day
- Previous close
- ₹1,744.00
- Open
- ₹1,744.00
- Day high
- ₹1,897.30
- Day low
- ₹1,699.00
Listed on NSE since 18 December 2024.
Key numbers
- Market value
- ₹37,929 Cr
- P/E (trailing)
- 101.54
- EPS (trailing)
- ₹17.58
- Price to book
- 15.22
- Dividend yield
- 0.00%
- Debt to equity
- 0.12
- Profit margin
- 16.1%
- Volume today
- 79.53 L
- Average volume
- 8.29 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹1,196.95 Cr | ₹9.99 Cr |
| FY24 | ₹1,456.47 Cr | ₹82.81 Cr |
| FY25 | ₹1,660.39 Cr | ₹170.13 Cr |
| FY26 | ₹2,136.83 Cr | ₹348.91 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹659 Cr | ₹98 Cr | – |
| Q1 FY27Apr–Jun 2026 | ₹554 Cr | ₹0 | −100.0% |
| Q4 FY26Jan–Mar 2026 | ₹602 Cr | ₹104 Cr | +18.1% |
| Q3 FY26Oct–Dec 2025 | ₹556 Cr | ₹0 | – |
| Q2 FY26Jul–Sep 2025 | ₹537 Cr | ₹0 | – |
| Q1 FY26Apr–Jun 2025 | ₹496 Cr | ₹60 Cr | – |
Source: Sai Life Sciences’s results filed with NSE, consolidated (the whole group). Net profit is the share of Sai Life Sciences’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹2,587 Cr | ₹2,079 Cr |
| Investments | ₹52 Cr | ₹51 Cr |
| Inventories | ₹242 Cr | ₹151 Cr |
| Owed by customers | ₹342 Cr | ₹374 Cr |
| Cash and equivalents | ₹31 Cr | ₹82 Cr |
| Total assets | ₹4,202 Cr | ₹3,626 Cr |
| Borrowings | ₹448 Cr | ₹95 Cr |
| Total liabilities | ₹1,514 Cr | ₹1,142 Cr |
| Shareholders’ equity | ₹2,688 Cr | ₹2,484 Cr |
Source: Sai Life Sciences’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Sai Life Sciences
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.
- Industry
- Diagnostics & Research
- Based in
- Hyderabad
- Employees
- 5,224
Company website · Profile: Yahoo Finance
In the news
All newsDividends and corporate actions
All companiesNSE lists no dividends or other corporate actions for Sai Life Sciences.
Information only, not investment advice. Prices are delayed.